Skip to main content

Histopathology of Early Mucosal Neoplasias: Morphologic Carcinogenesis in the GI Tract

  • Chapter
  • First Online:
  • 634 Accesses

Abstract

Endoscopists must be familiar with the macroscopic and histologic type of neoplasias, the potential for malignant conversion, and the kinetics of local and metastatic spread. Investigation into the morphogenesis of early cancer has revealed at least five different morphologic pathways of carcinogenesis in the colon, three different pathways in the stomach, and at least two in the esophagus. These pathways exhibit distinct macroscopic precursor and early malignant lesions. Endoscopic resection R0 en-bloc is curative in mucosal T1a and incipient T1b submucosal differentiated carcinomas of the gastric, esophageal or colonic wall. Apart from histologic grading and lymphatic or venous vascular invasion, vertical submucosal extension of early cancer predicts the probability of established lymph node metastases. To define the vertical and lateral margins of tumor infiltration after en-bloc resection, the specimen must be documented endoscopically and macroscopically and sent oriented to the pathology laboratory to obtain a precise pathological statement for decision on further management and follow-up.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Fujimori T, et al. Pathological diagnosis of early colorectal carcinoma and its clinical implications. Digestion. 2009;79(Suppl 1):40–51.

    Article  CAS  Google Scholar 

  2. Gotoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.

    Article  Google Scholar 

  3. Takubo K, et al. Early squamous cell carcinoma of the oesophagus: the Japanese viewpoint. Histopathology. 2007;51:733–42.

    Article  CAS  Google Scholar 

  4. Kudo S, et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc. 2008;68:S3–47.

    Article  Google Scholar 

  5. Sano Y, et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig Endosc. 2016;28:526–33.

    Article  Google Scholar 

  6. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58:S3–43.

    Google Scholar 

  7. Paris workshop on columnar metaplasia in the esophagus and the esophagogastric junction, Paris, France, December 11–12, 2004. Endoscopy. 2005;37:879–920.

    Google Scholar 

  8. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113–30.

    Article  CAS  Google Scholar 

  9. Lauren P. The Two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.

    Article  CAS  Google Scholar 

  10. Schlemper RJ, et al. Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer. 1998;82:60–9.

    Article  CAS  Google Scholar 

  11. Schlemper RJ, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet. 1997;349:1725–9.

    Article  CAS  Google Scholar 

  12. Schlemper RJ, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–5.

    Article  CAS  Google Scholar 

  13. Kudo SE. Early colorectal cancer. In:Detection of depressed types of colorectal carcinoma. Tokyo: IGAKU-SHOIN Ltd; 1996.

    Google Scholar 

  14. Muto M, et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig Endosc. 2016;28:379–93.

    Article  Google Scholar 

  15. Oyama T, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14:105–12.

    Article  Google Scholar 

  16. Ueno H, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127:385–94.

    Article  Google Scholar 

  17. Dunbar KB, et al. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2012;107:850–62. quiz 863

    Article  Google Scholar 

  18. Hirasawa T, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.

    Article  Google Scholar 

  19. Holscher AH, et al. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg. 2011;254:802–7; discussion 807–808.

    Article  Google Scholar 

  20. Kitajima K, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39:534–43.

    Article  Google Scholar 

  21. Stein HJ, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242:566–73; discussion 573–565.

    PubMed  PubMed Central  Google Scholar 

  22. Tajima Y, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–93.

    Article  CAS  Google Scholar 

  23. Lugli A, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30:1299–311.

    Article  Google Scholar 

  24. Watanabe T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1–34.

    Article  Google Scholar 

  25. Toyonaga T, et al. Principles of quality controlled endoscopic submucosal dissection with appropriate dissection level and high quality resected specimen. Clin Endosc. 2012;45:362–74.

    Article  Google Scholar 

  26. Vogelstein B, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.

    Article  CAS  Google Scholar 

  27. East JE, et al. Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance. Gut. 2015;64:991–1000.

    Article  Google Scholar 

  28. Guinney J, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350–6.

    Article  CAS  Google Scholar 

  29. Becht E, et al. Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy. Clin Cancer Res. 2016;22:4057–66.

    Article  CAS  Google Scholar 

  30. Hermanek P. Polypectomy in the colorectum histological and oncological aspects. Endoscopy. 1983;15(Suppl 1):158–61.

    Article  Google Scholar 

  31. Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med. 2009;361:1179–87.

    Article  CAS  Google Scholar 

  32. Uraoka T, et al. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut. 2006;55:1592–7.

    Article  CAS  Google Scholar 

  33. Goto H. Proportion of de novo cancers among colorectal cancers in Japan. Gastroenterology. 2006;131:40–6.

    Article  Google Scholar 

  34. Shimoda T, et al. Early colorectal carcinoma with special reference to its development de novo. Cancer. 1989;64:1138–46.

    Article  CAS  Google Scholar 

  35. Ijspeert JEG, et al. Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview. Gut. 2017;66:1225–32.

    Article  CAS  Google Scholar 

  36. Makinen MJ. Colorectal serrated adenocarcinoma. Histopathology. 2007;50:131–50.

    Article  CAS  Google Scholar 

  37. Oka S, et al. Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest Endosc. 2004;59:213–9.

    Article  Google Scholar 

  38. Leggett B, et al. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138:2088–100.

    Article  CAS  Google Scholar 

  39. De Jong AE, et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology. 2004;126:42–8.

    Article  Google Scholar 

  40. East JE, et al. Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut. 2008;57:65–70.

    Article  CAS  Google Scholar 

  41. Huneburg R, et al. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy. 2009;41:316–22.

    Article  CAS  Google Scholar 

  42. Lecomte T, et al. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol. 2005;3:897–902.

    Article  Google Scholar 

  43. Lynch HT, et al. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–32.

    Article  CAS  Google Scholar 

  44. Rijcken FE, et al. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut. 2002;50:382–6.

    Article  CAS  Google Scholar 

  45. Watanabe T, et al. Flat adenoma as a precursor of colorectal carcinoma in hereditary nonpolyposis colorectal carcinoma. Cancer. 1996;77:627–34.

    Article  CAS  Google Scholar 

  46. Laine L, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489–501. e426.

    Article  Google Scholar 

  47. Magro F, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and Ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–70.

    Article  Google Scholar 

  48. Chiu K, et al. DALM, rest in peace: a pathologist’s perspective on dysplasia in inflammatory bowel disease in the post-DALM era. Mod Pathol. 2018;31:1080–90.

    Article  Google Scholar 

  49. Lim CH, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut. 2003;52:1127–32.

    Article  CAS  Google Scholar 

  50. Soetikno R, et al. Paradigm shift in the surveillance and management of dysplasia in inflammatory bowel disease (West). Dig Endosc. 2016;28:266–73.

    Article  Google Scholar 

  51. Thomas T, et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657–68.

    Article  CAS  Google Scholar 

  52. Blair V, et al. Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol. 2006;4:262–75.

    Article  CAS  Google Scholar 

  53. Cislo M, et al. Distinct molecular subtypes of gastric cancer: from Lauren to molecular pathology. Oncotarget. 2018;9:19427–42.

    Article  Google Scholar 

  54. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.

    Article  Google Scholar 

  55. Sobin LH, et al. TNM classification of malignant tumours. Oxford: Wiley-Blackwell; 2009.

    Google Scholar 

  56. Namikawa T, et al. Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma. World J Gastroenterol. 2010;16:4634–9.

    Article  Google Scholar 

  57. Yamazaki K, et al. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol. 2006;12:3803–9.

    Article  CAS  Google Scholar 

  58. Tajima Y, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res. 2006;12:6469–79.

    Article  CAS  Google Scholar 

  59. Hirota WK, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570–80.

    Article  Google Scholar 

  60. Vieth M, et al. Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch. 2003;442:317–21.

    CAS  PubMed  Google Scholar 

  61. Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–8.

    Article  Google Scholar 

  62. Yao K, et al. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41:462–7.

    Article  CAS  Google Scholar 

  63. Engel LS, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–13.

    Article  Google Scholar 

  64. Quante M, et al. Insights into the pathophysiology of esophageal adenocarcinoma. Gastroenterology. 2018;154:406–20.

    Article  CAS  Google Scholar 

  65. Buttar NS, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630–9.

    Article  CAS  Google Scholar 

  66. Leers JM, et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg. 2011;253:271–8.

    Article  Google Scholar 

  67. Landau MS, et al. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol. 2014;27:1578–89.

    Article  CAS  Google Scholar 

  68. Zemler B, et al. Early Barrett’s carcinoma: the depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion. Virchows Arch. 2010;456:609–14.

    Article  Google Scholar 

  69. Yokoyama A, et al. Risk appraisal and endoscopic screening for esophageal squamous cell carcinoma in Japanese populations. Esophagus. 2007;4:135–43.

    Article  Google Scholar 

  70. Nagata K, Shimizu M. Pathological evaluation of gastrointestinal endoscopic submucosal dissection materials based on Japanese guidelines. World J Gastrointest Endosc. 2012;4:489–99.

    Article  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge Susanna Mueller, M.D., Department of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany; and Manfred Stolte, M.D., Institut für Pathologie, Kulmbach, for proofreading of the chapter and focusing on the formal differences in histopathologic criteria of cancer diagnosis used by Japanese and Western pathologists.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Neureiter .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Neureiter, D., Kiesslich, T. (2019). Histopathology of Early Mucosal Neoplasias: Morphologic Carcinogenesis in the GI Tract. In: Berr, F., Oyama, T., Ponchon, T., Yahagi, N. (eds) Atlas of Early Neoplasias of the Gastrointestinal Tract. Springer, Cham. https://doi.org/10.1007/978-3-030-01114-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01114-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01113-0

  • Online ISBN: 978-3-030-01114-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics